As Becton Dickinson & Co (NYSE:BDX) Price Declined, Shareholder Mackenzie Financial Corp Upped Position

May 16, 2018 - By Julia Grubbs

Becton, Dickinson and Company (NYSE:BDX) Corporate LogoDuring Q4 2017 the big money sentiment increased to 1.55. That’s change of 0.62, from 2017Q3’s 0.93. 50 investors sold all, 294 reduced holdings as BDX ratio increased. 386 rose stakes while 147 funds bought stakes. Funds hold 215.77 million shares thus 9.23% more from 2017Q3’s 197.53 million shares. Vontobel Asset Mngmt reported 110,247 shs or 0.17% of all its holdings. Cheviot Value Limited Liability owns 18,527 shs or 2.05% of their US capital. Palisade Capital Ltd Limited Liability Company Nj has invested 0.39% of its capital in Becton, Dickinson and Company (NYSE:BDX). Fiera Cap Corporation has 2.81% invested in Becton, Dickinson and Company (NYSE:BDX). 37,567 are held by Fifth Third Comml Bank. 6,700 were reported by Wheatland Advsr. Robeco Institutional Asset Mgmt Bv has invested 0.17% of its capital in Becton, Dickinson and Company (NYSE:BDX). Roberts Glore Il has invested 0.77% in Becton, Dickinson and Company (NYSE:BDX). 695 were reported by Qci Asset. Bryn Mawr Tru has 1.84% invested in Becton, Dickinson and Company (NYSE:BDX). Livingston Group Inc Asset Mgmt (Operating As Southport Cap Management) owns 2,454 shs for 0.2% of their capital. Kj Harrison And Prtnrs accumulated 18,000 shs. Cim Investment Mangement Inc holds 0.2% or 2,740 shs. Ami Asset Corp holds 2.99% or 202,649 shs in its capital. Northeast Management invested in 0.03% or 1,680 shs.

BDX registered $4.78 million net activity with 1 buying transaction and 5 insider sales since February 23, 2018. On Monday, May 7 Melcher David F had bought 500 shs worth $112,535. $1.21M worth of Becton, Dickinson and Company (NYSE:BDX) was sold by Gallagher John E. $910,726 worth of Becton, Dickinson and Company (NYSE:BDX) was sold by Borzi James W. $38,416 worth of Becton, Dickinson and Company (NYSE:BDX) was sold by RING TIMOTHY M. Shares for $2.31M were sold by Shabshab Nabil on Friday, May 11.

In 2018Q1 Securities and Exchange filling was reported Mackenzie Financial Corp’s holdings in Becton Dickinson & Co (NYSE:BDX) which was increased by 18.75%. Becton Dickinson & Co (NYSE:BDX) stock Sank 1.94% while Mackenzie Financial Corp bought 180,176 shares. In 2018Q1, the 1.14M shares in Becton Dickinson & Co (NYSE:BDX) held by Mackenzie Financial Corp were priced $247.28M, up from 960,926 last quarter. $60.09B is the Becton Dickinson & Co’s market cap. BDX hit $224.87 during the last trading session after $0.12 change.Becton, Dickinson and Company has 1.20 million shares volume, 3.28% up from normal. BDX is uptrending and has moved 15.92% since May 17, 2017. BDX outperformed by 4.37% the S&P500.

Mackenzie Financial Corp operates about $61.70 billion and $39.23 billion US longs. It reduced its stake in Amazon Com Inc (NASDAQ:AMZN) by 8,380 shares to 44,678 shares, valued at $64.66 million in 2018Q1, according to the filling. It decreased Abbvie Inc (NYSE:ABBV) position by 189,554 shares to 571,518 shares, and cut its Teck Resources Ltd (NYSE:TCK) stake.

Mackenzie Financial Corp is a Ontario, Canada-based hedge fund with more than $61.70 billion AUM in March, 2014. This fund invests only a small percentage of its assets in equities and options. Mackenzie Financial Corp is the 80th largest hedge fund in our database. Taken from Mackenzie Financial latest Adv, the fund reported to have 1006 full and part-time employees. Among which 70 performing investment advisory and research functions. The hedge fund had more than 200 clients.

Becton, Dickinson and Company (NYSE:BDX) Ratings Coverage

Total analysts of 12 have positions in Becton Dickinson (NYSE:BDX) as follows: 9 rated it a “Buy”, 0 with “Sell” and 3 with “Hold”. The positive are 75%. Since December 14, 2017 according to StockzIntelligence Inc Becton Dickinson has 13 analyst reports. On Wednesday, December 20 the stock has “Buy” rating by Cowen & Co. On Tuesday, February 6 the rating was maintained by Jefferies with “Buy”. On Thursday, February 8 the stock of Becton, Dickinson and Company (NYSE:BDX) earned “Hold” rating by RBC Capital Markets. On Friday, December 29 the stock of Becton, Dickinson and Company (NYSE:BDX) earned “Buy” rating by Deutsche Bank. The stock rating was maintained by Morgan Stanley with “Equal-Weight” on Wednesday, February 7. The company rating was upgraded by Citigroup on Tuesday, April 10. On Friday, January 5 the rating was upgraded by Citigroup to “Hold”. The stock rating was maintained by Piper Jaffray with “Buy” on Tuesday, February 6.

Becton, Dickinson and Company develops, makes, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide.The firm is valued at $60.09 billion. It operates in two divisions, BD Medical and BD Life Sciences.Currently it has negative earnings. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems.

Becton, Dickinson and Company (NYSE:BDX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: